BridgeBio Pharma, Inc. is a pharma company. The company is headquartered in Palo Alto, California and currently employs 185 full-time employees. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene therapy. The Company’s pipeline programs include product candidates ranging from early discovery to late-stage development. The Company’s products include BBP-265, BBP-831, BBP-631 and BBP-454.